Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
Int J Tuberc Lung Dis. 2016 Jul;20(7):866-9. doi: 10.5588/ijtld.16.0034.
Int J Tuberc Lung Dis. 2016.
PMID: 27287636
Review.
Treatment guidance for non-multidrug-resistant (MDR) rifampicin-resistant (RMP-R) tuberculosis (TB) is variable. We aimed to undertake a systematic review and meta-analysis of the randomised controlled trial (RCT) data behind such guidelines to identify the most efficaciou …
Treatment guidance for non-multidrug-resistant (MDR) rifampicin-resistant (RMP-R) tuberculosis (TB) is variable. We aimed to undertak …